Director/PDMR Shareholding

RNS Number : 4828P

AstraZeneca PLC

25 March 2009

 



Transaction by Persons Discharging Managerial Responsibilities

Disclosure Rule DTR 3.1.4

We hereby inform you that on 24 March 2009, the interest of the following Directors in AstraZeneca PLC Ordinary Shares of $0.25 each changed as detailed below. The change in interest relates to the vesting of previously announced awards made in March 2006 under the AstraZeneca Performance Share Plan whereby, following the application of performance measures specified at the time of grant, the individuals concerned have now become beneficially entitled to 89% of the shares originally awarded. In accordance with the plan rules, the unvested part of the award has immediately and irrevocably lapsed. In each case, sufficient vested shares were withheld to cover certain tax obligations arising on the vesting.

Name of Director	Number of Shares Awarded	Number of Shares Lapsed	Number of Shares Vested	Number of Shares Withheld	Net Number of Shares	Current Holding	Percentage of Issued Share Capital
David R Brennan	73,109	8,042	65,067	26,678	38,389	See below	See below
John Patterson	32,319	3,555	28,764	11,794	16,970	144,353	0.01%

Mr Brennan has interests in both the Ordinary Shares and the American Depositary Shares (ADSs) of AstraZeneca PLC. One ADS equals one Ordinary Share.

As a result of this transaction, Mr Brennan's interest is now 376,641 Ordinary Shares and 76,188 AstraZeneca ADSs, which together represent approximately 0.031% of the Company's issued ordinary capital.

The market price of AstraZeneca PLC Ordinary Shares of $0.25 each on 24 March 2009 was 2287 pence.

A C N Kemp

Company Secretary

25 March 2009

 

END

 

 

RDSUVSVRKWROUAR